98 related articles for article (PubMed ID: 7996869)
1. Inv(16) may be one of the only 'favorable' factors in acute myeloid leukemia: a report on 19 cases with prolonged follow-up.
Plantier I; Lai JL; Wattel E; Bauters F; Fenaux P
Leuk Res; 1994 Dec; 18(12):885-8. PubMed ID: 7996869
[TBL] [Abstract][Full Text] [Related]
2. Acute myeloid leukemia with translocation (8;21) or inversion (16) in elderly patients treated with conventional chemotherapy: a collaborative study of the French CBF-AML intergroup.
Prébet T; Boissel N; Reutenauer S; Thomas X; Delaunay J; Cahn JY; Pigneux A; Quesnel B; Witz F; Thépot S; Ugo V; Terre C; Recher C; Tavernier E; Hunault M; Esterni B; Castaigne S; Guilhot F; Dombret H; Vey N; ; ;
J Clin Oncol; 2009 Oct; 27(28):4747-53. PubMed ID: 19720919
[TBL] [Abstract][Full Text] [Related]
3. Cytogenetic and clinical correlates in AML patients with abnormalities of chromosome 16.
Marlton P; Keating M; Kantarjian H; Pierce S; O'Brien S; Freireich EJ; Estey E
Leukemia; 1995 Jun; 9(6):965-71. PubMed ID: 7596186
[TBL] [Abstract][Full Text] [Related]
4. [Long term follow-up of three cases of acute myeloid leukemia associated with inv(16)(p13q22)].
Miura I; Cyubachi A; Hashimoto K; Nishinari T; Nimura T; Miura AB
Rinsho Ketsueki; 1993 Aug; 34(8):942-5. PubMed ID: 8411649
[TBL] [Abstract][Full Text] [Related]
5. Therapy-related acute myeloid leukemia with t(8;21), inv(16), and t(8;16): a report on 25 cases and review of the literature.
Quesnel B; Kantarjian H; Bjergaard JP; Brault P; Estey E; Lai JL; Tilly H; Stoppa AM; Archimbaud E; Harousseau JL
J Clin Oncol; 1993 Dec; 11(12):2370-9. PubMed ID: 8246025
[TBL] [Abstract][Full Text] [Related]
6. [Bulky lymphadenopathy in acute myeloid leukemia with inv (16) (p13q22): a case report].
Zhou HF; Li JY; Qian SX; Qiu HR; Zhang SJ; Zhang JF; Wu YJ; Shen RL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Oct; 14(5):1033-7. PubMed ID: 17096914
[TBL] [Abstract][Full Text] [Related]
7. Impact of an Additional Chromosome on the Clinical Outcomes of Hematopoietic Stem Cell Transplantation in Philadelphia Chromosome-Positive Acute Myeloid Leukemia in Adults.
Min GJ; Kim HJ; Yoon JH; Kwak DH; Park SS; Jeon YW; Lee SE; Cho BS; Eom KS; Kim YJ; Lee S; Min CK; Cho SG; Kim DW; Lee JW; Min WS
Biol Blood Marrow Transplant; 2018 Aug; 24(8):1621-1628. PubMed ID: 29698793
[TBL] [Abstract][Full Text] [Related]
8. Patients with de novo acute myeloid leukaemia and complex karyotype aberrations show a poor prognosis despite intensive treatment: a study of 90 patients.
Schoch C; Haferlach T; Haase D; Fonatsch C; Löffler H; Schlegelberger B; Staib P; Sauerland MC; Heinecke A; Büchner T; Hiddemann W;
Br J Haematol; 2001 Jan; 112(1):118-26. PubMed ID: 11167792
[TBL] [Abstract][Full Text] [Related]
9. Detection of CBFB/MYH11 transcripts in patients with inversion and other abnormalities of chromosome 16 at presentation and remission.
Tobal K; Johnson PR; Saunders MJ; Harrison CJ; Liu Yin JA
Br J Haematol; 1995 Sep; 91(1):104-8. PubMed ID: 7577615
[TBL] [Abstract][Full Text] [Related]
10. Secondary acute myeloid leukemia with inv(16): report of two cases following paclitaxel-containing chemotherapy and review of the role of intensified ara-C therapy.
Seymour JF; Juneja SK; Campbell LJ; Ellims PH; Estey EH; Prince HM
Leukemia; 1999 Nov; 13(11):1735-40. PubMed ID: 10557046
[TBL] [Abstract][Full Text] [Related]
11. Most Myeloid Neoplasms With Deletion of Chromosome 16q Are Distinct From Acute Myeloid Leukemia With Inv(16)(p13.1q22): A Bone Marrow Pathology Group Multicenter Study.
Rogers HJ; Hsi ED; Tang G; Wang SA; Bueso-Ramos CE; Lubin D; Morrissette JJ; Bagg A; Cherukuri DP; George TI; Peterson L; Liu YC; Mathew S; Orazi A; Hasserjian RP
Am J Clin Pathol; 2017 Apr; 147(4):411-419. PubMed ID: 28375434
[TBL] [Abstract][Full Text] [Related]
12. [Additional chromosomal abnormality of inv(16)(p13q22) to del(7)(q32) in a patient with acute myelomonocytic leukemia].
Ida T; Hashimoto S; Yano T; Sato N; Koike T
Rinsho Ketsueki; 2012 Mar; 53(3):347-51. PubMed ID: 22499053
[TBL] [Abstract][Full Text] [Related]
13. Repetitive cycles of high-dose cytarabine benefit patients with acute myeloid leukemia and inv(16)(p13q22) or t(16;16)(p13;q22): results from CALGB 8461.
Byrd JC; Ruppert AS; Mrózek K; Carroll AJ; Edwards CG; Arthur DC; Pettenati MJ; Stamberg J; Koduru PR; Moore JO; Mayer RJ; Davey FR; Larson RA; Bloomfield CD
J Clin Oncol; 2004 Mar; 22(6):1087-94. PubMed ID: 15020610
[TBL] [Abstract][Full Text] [Related]
14. Inversion of chromosome 16 and uncommon rearrangements of the CBFB and MYH11 genes in therapy-related acute myeloid leukemia: rare events related to DNA-topoisomerase II inhibitors?
Dissing M; Le Beau MM; Pedersen-Bjergaard J
J Clin Oncol; 1998 May; 16(5):1890-6. PubMed ID: 9586906
[TBL] [Abstract][Full Text] [Related]
15. Balanced chromosome abnormalities inv(16) and t(15;17) in therapy-related myelodysplastic syndromes and acute leukemia: report from an international workshop.
Andersen MK; Larson RA; Mauritzson N; Schnittger S; Jhanwar SC; Pedersen-Bjergaard J
Genes Chromosomes Cancer; 2002 Apr; 33(4):395-400. PubMed ID: 11921273
[TBL] [Abstract][Full Text] [Related]
16. Inv(16) acute myeloid leukemia cells show an increased sensitivity to cytosine arabinoside in vitro.
Tosi P; Visani G; Ottaviani E; Testoni N; Pellacani A; Tura S
Eur J Haematol; 1998 Mar; 60(3):161-5. PubMed ID: 9548414
[TBL] [Abstract][Full Text] [Related]
17. A unique pattern of central nervous system leukemia in acute myelomonocytic leukemia associated with inv(16)(p13q22).
Holmes R; Keating MJ; Cork A; Broach Y; Trujillo J; Dalton WT; McCredie KB; Freireich EJ
Blood; 1985 May; 65(5):1071-8. PubMed ID: 3857943
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors and outcome of core binding factor acute myeloid leukemia patients with t(8;21) differ from those of patients with inv(16): a Cancer and Leukemia Group B study.
Marcucci G; Mrózek K; Ruppert AS; Maharry K; Kolitz JE; Moore JO; Mayer RJ; Pettenati MJ; Powell BL; Edwards CG; Sterling LJ; Vardiman JW; Schiffer CA; Carroll AJ; Larson RA; Bloomfield CD
J Clin Oncol; 2005 Aug; 23(24):5705-17. PubMed ID: 16110030
[TBL] [Abstract][Full Text] [Related]
19. Chromosome change at 16q22 in nonlymphocytic leukemia: clinical implication on leukemia patients with inv(16) versus del(16).
Ohyashiki K; Ohyashiki JH; Kondo M; Ito H; Toyama K
Leukemia; 1988 Jan; 2(1):35-40. PubMed ID: 3422328
[TBL] [Abstract][Full Text] [Related]
20. Acute myeloid leukemia with inv(16)(p13q22): involvement of cervical lymph nodes and tonsils is common and may be a negative prognostic sign.
Billström R; Ahlgren T; Békássy AN; Malm C; Olofsson T; Höglund M; Mitelman F; Johansson B
Am J Hematol; 2002 Sep; 71(1):15-9. PubMed ID: 12221668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
